Table 3.
Group | SOD (U/ml) | GSH (mg/L) | MDA (nmol/ml) | LG (mg/g) |
NCG | 113.18±0.86 | 18.26±2.44 | 4.73±0.91 | 9.90±1.04 |
DCG | 37.81±7.74## | 8.45±1.22## | 19.36±0.72## | 3.36±0.71## |
MG | 76.14±2.44** | 15.89±1.26** | 8.79±1.45** | 7.28±0.90** |
PSPE 50 | 47.56±4.15** | 9.80±0.60 | 17.54±0.96 | 3.83±0.16 |
PSPE 100 | 56.90±2.68** | 11.63±1.23** | 14.82±2.12** | 5.17±0.22** |
PSPE 200 | 70.51±2.49** | 13.66±1.00** | 10.24±1.11** | 6.33±0.40** |
Results are expressed as the mean±SD (n=7). SOD: superoxide dismutase; GSH: glutathione; MDA: methane dicarboxylic aldehyde; LG: liver glycogen; NCG: normal control group; DCG: diabetic control group; MG: diabetic rats treated with Met (200 mg/kg); PSPE 50: diabetic rats treated with PSPE (50 mg/kg, oral); PSPE 100: diabetic rats treated with PSPE (100 mg/kg, oral); PSPE 200: diabetic rats treated with PSPE (200 mg/kg, oral).
P<0.01, compared with NCG;
P<0.01, compared with DCG